Jump to content

Talk:Ibrutinib

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Can we reduce width on chembox on right

[edit]

Currently (at least for me in Firefox) it looks about 40 chars wide and would be better at about half the current width. Can't see what sets the display width. - Rod57 (talk) 23:45, 9 April 2013 (UTC)[reply]

OK now. - Rod57 (talk) 14:15, 20 November 2016 (UTC)[reply]

Why no mention of atrial fibrillation as adverse effect

[edit]

atrial fibrillation not mentioned in Adverse effects - despite efforts to treat IRAF eg [1], and that review saying different studies reported 5, 6 or 7% incidence of AF with ibrutinib use. - Rod57 (talk) 14:34, 20 November 2016 (UTC)[reply]

old refs. updated them, and content based on them. Jytdog (talk) 21:27, 20 November 2016 (UTC)[reply]

Bleeding

[edit]

Is common doi:10.1111/jth.13651 JFW | T@lk 21:28, 2 May 2017 (UTC)[reply]

So common that this is the second review in a short period! doi:10.1182/bloodadvances.2016001883 JFW | T@lk 20:38, 9 May 2017 (UTC)[reply]

New text

[edit]

"Ibrutinib is now the preferred first-line treatment for most patients with CLL"

One of the issue with this paper is that some of the authors are being paid by AbbVie.[2]

Add to that that the authors appear to be trying to add it themselves.

Table 2 lists a number of first line treatments. Doc James (talk · contribs · email) 18:27, 17 February 2019 (UTC)[reply]

Found a better ref, NCI. https://www.cancer.gov/types/leukemia/hp/cll-treatment-pdq Doc James (talk · contribs · email) 00:38, 19 February 2019 (UTC)[reply]

US cost of Imbruvica -- reference, and add to Economic section

[edit]

Treatment cost of Imbruvica $160,000 per year cited in Congressional hearing by Rep Ro Khanna of California on 10 Feb 2024. https://twitter.com/perry_ron/status/1756319357179953277 217.155.151.38 (talk) 12:40, 11 February 2024 (UTC)[reply]